Black Diamond Therapeutics
Quarterly Financials
| Values in thousands | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
Revenue | $0 | $70,000 | $516 | $0 |
Gross Profit | -86 | 70,000 | 258 | -86 |
EBITDA | -13,420 | 54,617 | -18,190 | -18,044 |
EBIT | -13,506 | 54,530 | -18,275 | -18,130 |
Net Income | -10,561 | 56,542 | -15,985 | -15,557 |
Net Change In Cash | 0 | 70,000 | 516 | 0 |
Free Cash Flow | -9,159 | 53,410 | -15,055 | -11,323 |
Cash | 29,993 | 98,424 | 36,437 | 23,425 |
Basic Shares | 56,803 | 57,673 | 56,607 | 56,507 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -343 | -437 | -3,238 | -2,217 |
EBITDA | -69,333 | -86,023 | -92,320 | -126,667 |
EBIT | -69,676 | -86,460 | -92,828 | -126,872 |
Net Income | -69,676 | -82,442 | -91,169 | -125,596 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Cost of Revenue | -31,539 | 31,194 | ||
Free Cash Flow | -62,303 | -66,750 | -85,274 | -102,858 |
Cash | 36,437 | 56,221 | 34,315 | 65,799 |
Basic Shares | 55,028 | 43,954 | 36,325 | 36,189 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-09-30 | $0 |
2025-06-30 | -$0.19 |
2025-03-31 | $0.98 |
2024-12-31 | -$0.28 |
